Literature DB >> 30926321

Physical activity and associations with clinical outcome measures in adults with cystic fibrosis; a systematic review.

James Shelley1, Lynne M Boddy2, Zoe R Knowles2, Claire E Stewart2, Ellen A Dawson2.   

Abstract

BACKGROUND: Physical activity (PA) is important in the management of Cystic Fibrosis (CF) and is associated with a number of beneficial effects. PA assessment is not commonplace or consistent in clinical practice, therefore understanding of PA in adults with CF remains limited. The purpose of this review was to evaluate PA levels in this population and compare PA to global recommendations and non-CF peers.
METHODS: The Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines were utilised to inform the review process. Original research was identified and screened against inclusion/exclusion criteria. Quality was assessed, data extracted and a narrative synthesis undertaken to describe the findings.
RESULTS: Adults with CF did not achieve recommended PA guidelines and step count targets in 5/8 studies where assessment was possible. No significant differences in PA were found between CF and non-CF peers in 3/5 studies. Associations between PA and improved lung function were inconsistent with 4/9 studies finding a positive association. Evidence for an association between PA and higher exercise capacity was stronger with all 4 studies reviewed reporting a positive association. Quality ratings were low across all studies.
CONCLUSIONS: PA in adults with CF is largely comparable to their non-CF peers, despite being insufficiently active to achieve PA recommendations. Assessment tools used and outcomes reported are variable, many of which do not provide sufficient information to assess relevant components of PA. There is a requirement for high quality studies designed specifically to explore PA in adults with CF, ideally employing standardised PA assessment methods.
Copyright © 2019 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Exercise; PRISMA; Quality of life; Respiratory disease

Year:  2019        PMID: 30926321     DOI: 10.1016/j.jcf.2019.03.003

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  6 in total

Review 1.  Physical activity and exercise training in cystic fibrosis.

Authors:  Thomas Radtke; Sherie Smith; Sarah J Nevitt; Helge Hebestreit; Susi Kriemler
Journal:  Cochrane Database Syst Rev       Date:  2022-08-09

2.  A Compositional Analysis of Physical Activity, Sedentary Time, and Sleep and Associated Health Outcomes in Children and Adults with Cystic Fibrosis.

Authors:  Mayara S Bianchim; Melitta A McNarry; Anne Holland; Narelle S Cox; Julianna Dreger; Alan R Barker; Craig A Williams; Sarah Denford; Kelly A Mackintosh
Journal:  Int J Environ Res Public Health       Date:  2022-04-23       Impact factor: 4.614

3.  Gaming Console Home-Based Exercise for Adults with Cystic Fibrosis: Study Protocol.

Authors:  John D Lowman; George M Solomon; Steven M Rowe; Hon K Yuen
Journal:  Int J Caring Sci       Date:  2020 Spring/Summer

4.  The impact of physical activity and exercise interventions for physical health in people with cystic fibrosis: protocol for a systematic review.

Authors:  Owen W Tomlinson; Sarah Denford; Alan R Barker; Jane E Schneiderman; Emma S Campisi; Helen Douglas; Sarah Rand; Melitta A McNarry; Kelly A Mackintosh; Craig A Williams
Journal:  Syst Rev       Date:  2021-02-26

5.  Developing an ecological approach to physical activity promotion in adults with Cystic fibrosis.

Authors:  James Shelley; Ellen A Dawson; Lynne M Boddy; Claire E Stewart; Freddy Frost; Dilip Nazareth; Martin J Walshaw; Zoe R Knowles
Journal:  PLoS One       Date:  2022-08-01       Impact factor: 3.752

6.  New strategies of physical activity assessment in cystic fibrosis: a pilot study.

Authors:  Daniela Savi; Luigi Graziano; Barbara Giordani; Stefano Schiavetto; Corrado De Vito; Giuseppe Migliara; Nicholas J Simmonds; Paolo Palange; J Stuart Elborn
Journal:  BMC Pulm Med       Date:  2020-10-30       Impact factor: 3.317

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.